PT - JOURNAL ARTICLE AU - Nan Liu AU - Marcel Lucas Chee AU - Chenglin Niu AU - Pin Pin Pek AU - Fahad Javaid Siddiqui AU - John Pastor Ansah AU - David Bruce Matchar AU - Sean Shao Wei Lam AU - Hairil Rizal Abdullah AU - Angelique Chan AU - Rahul Malhotra AU - Nicholas Graves AU - Mariko Siyue Koh AU - Sungwon Yoon AU - Andrew Fu Wah Ho AU - Daniel Shu Wei Ting AU - Jenny Guek Hong Low AU - Marcus Eng Hock Ong TI - Coronavirus Disease 2019 (COVID-19): An Evidence Map of Medical Literature AID - 10.1101/2020.05.07.20093674 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.07.20093674 4099 - http://medrxiv.org/content/early/2020/05/11/2020.05.07.20093674.short 4100 - http://medrxiv.org/content/early/2020/05/11/2020.05.07.20093674.full AB - Since the beginning of the COVID-19 outbreak in December 2019, a substantial body of COVID-19 medical literature has been generated. As of May 2020, gaps in the existing literature remain unidentified and, hence, unaddressed. In this paper, we summarise the medical literature on COVID-19 between 1 January and 24 March 2020 using evidence maps and bibliometric analysis in order to systematically identify gaps and propose areas for valuable future research. The examined COVID-19 medical literature originated primarily from Asia and focussed mainly on clinical features and diagnosis of the disease. Many areas of potential research remain underexplored, such as mental health research, the use of novel technologies and artificial intelligence, research on the pathophysiology of COVID-19 within different body systems, and research on indirect effects of COVID-19 on the care of non-COVID-19 patients. Research collaboration at the international level was limited although improvements may aid global containment efforts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Duke-NUS Signature Research Programme funded by the Ministry of Health, Singapore.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.